365 related articles for article (PubMed ID: 10616683)
1. Lambert-Eaton myasthenic syndrome.
Seneviratne U; de Silva R
Postgrad Med J; 1999 Sep; 75(887):516-20. PubMed ID: 10616683
[TBL] [Abstract][Full Text] [Related]
2. A treatment algorithm for Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():817-22. PubMed ID: 9668335
[No Abstract] [Full Text] [Related]
3. Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
[TBL] [Abstract][Full Text] [Related]
4. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
Titulaer MJ; Lang B; Verschuuren JJ
Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
[TBL] [Abstract][Full Text] [Related]
5. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
6. Lambert-Eaton myasthenic syndrome (LEMS). Clinical and electrodiagnostic features and response to therapy in 59 patients.
Tim RW; Massey JM; Sanders DB
Ann N Y Acad Sci; 1998 May; 841():823-6. PubMed ID: 9668336
[No Abstract] [Full Text] [Related]
7. Lambert Eaton syndrome: autonomic neuropathy and inappropriate antidiuretic hormone secretion in a patient with small cell carcinoma of the lung.
Manji H; Schwartz MS; McKeran RO
J Neurol; 1990 Aug; 237(5):324-5. PubMed ID: 2172471
[TBL] [Abstract][Full Text] [Related]
8. Apheresis treatment in Lambert-Eaton myasthenic syndrome.
Motomura M; Hamasaki S; Nakane S; Fukuda T; Nakao YK
Ther Apher; 2000 Aug; 4(4):287-90. PubMed ID: 10975475
[TBL] [Abstract][Full Text] [Related]
9. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.
Mason WP; Graus F; Lang B; Honnorat J; Delattre JY; Valldeoriola F; Antoine JC; Rosenblum MK; Rosenfeld MR; Newsom-Davis J; Posner JB; Dalmau J
Brain; 1997 Aug; 120 ( Pt 8)():1279-300. PubMed ID: 9278623
[TBL] [Abstract][Full Text] [Related]
10. [Lambert-Eaton myasthenic syndrome (LEMS)].
Suzuki S
Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
[TBL] [Abstract][Full Text] [Related]
11. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
Schneider I; Kornhuber ME; Hanisch F
J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
[TBL] [Abstract][Full Text] [Related]
12. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
Sakai W; Nakane S; Matsuo H
Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
[TBL] [Abstract][Full Text] [Related]
13. Lambert-Eaton myasthenic syndrome - diagnosis, pathogenesis and therapy.
Hülsbrink R; Hashemolhosseini S
Clin Neurophysiol; 2014 Dec; 125(12):2328-36. PubMed ID: 25065299
[TBL] [Abstract][Full Text] [Related]
14. [Lambert-Eaton Myasthenic Syndrome].
Matsuo H
Brain Nerve; 2024 May; 76(5):630-634. PubMed ID: 38741506
[TBL] [Abstract][Full Text] [Related]
15. Available treatment options for the management of Lambert-Eaton myasthenic syndrome.
Verschuuren JJ; Wirtz PW; Titulaer MJ; Willems LN; van Gerven J
Expert Opin Pharmacother; 2006 Jul; 7(10):1323-36. PubMed ID: 16805718
[TBL] [Abstract][Full Text] [Related]
16. Lambert-Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer.
Schoser B; Eymard B; Datt J; Mantegazza R
J Neurol; 2017 Sep; 264(9):1854-1863. PubMed ID: 28608304
[TBL] [Abstract][Full Text] [Related]
17. Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome.
Oh SJ; Kim DS; Kwon KH; Tseng A; Mussell H; Claussen GC
Ann N Y Acad Sci; 1998 May; 841():827-31. PubMed ID: 9668337
[No Abstract] [Full Text] [Related]
18. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
Takamori M
J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
[TBL] [Abstract][Full Text] [Related]
19. Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma.
Chalk CH; Murray NM; Newsom-Davis J; O'Neill JH; Spiro SG
Neurology; 1990 Oct; 40(10):1552-6. PubMed ID: 2170866
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
Takano H; Tanaka M; Koike R; Nagai H; Arakawa M; Tsuji S
Muscle Nerve; 1994 Sep; 17(9):1073-5. PubMed ID: 8065398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
